BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2084458)

  • 1. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
    Espiritu-Quiza MF; Skinner MH; Blaschke TF
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole is a potent inhibitor of antipyrine metabolism in vivo in mice.
    La Delfa I; Zhu QM; Mo Z; Blaschke TF
    Drug Metab Dispos; 1989; 17(1):49-53. PubMed ID: 2566469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon reduces hepatic drug metabolism in vivo in mice.
    Taylor G; Marafino BJ; Moore JA; Gurley V; Blaschke TF
    Drug Metab Dispos; 1985; 13(4):459-63. PubMed ID: 2863111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
    Tse FL; Chang T; Jaffe JM
    Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting enhancement of CYP activity after discontinuation of repeated administration of phenobarbital in dogs.
    Fukunaga K; Saito M; Matsuo E; Muto M; Mishima K; Fujiwara M; Orito K
    Res Vet Sci; 2009 Dec; 87(3):455-7. PubMed ID: 19406444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
    Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
    Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cimetidine and ranitidine on trimethadione metabolism in the rat.
    Tanaka E; Misawa S
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):461-4. PubMed ID: 3992022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of combined pre-treatment on the metabolism of antipyrine in the rat.
    Szabó I; Renczes G; Gachályi B
    Acta Physiol Hung; 1995; 83(1):51-3. PubMed ID: 7660837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo measurement of expired 14CO2 derived from the N-demethylation of aminopyrine as a reflection of the in vitro hepatic cytochrome P-450 drug-metabolism activity in rats.
    Kotake AN; Schreider BD; Latts JR
    Drug Metab Dispos; 1982; 10(3):251-8. PubMed ID: 6125358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
    McManus ME; Ilett KF
    Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a PCN-P450 enzyme in chickens and comparison of its development with that of other phenobarbital-inducible forms.
    Lorr NA; Bloom SE; Park SS; Gelboin HV; Miller H; Friedman FK
    Mol Pharmacol; 1989 May; 35(5):610-6. PubMed ID: 2725470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of antipyrine clearance by polysaccharide peptide (PSP) isolated from Coriolus versicolor in the rat.
    Chan SL; Yeung JH
    Food Chem Toxicol; 2006 Sep; 44(9):1607-12. PubMed ID: 16698162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of aging on the metabolism of simultaneously administered hexobarbital enantiomers and antipyrine before and after phenobarbital induction in male rats: a longitudinal study.
    Groen K; Breimer DD; Jansen EJ; van Bezooijen CF
    J Pharmacol Exp Ther; 1994 Feb; 268(2):531-6. PubMed ID: 8113964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prolonged oral cimetidine, ranitidine, and famotidine therapy on antipyrine elimination.
    Sakaue H; Akamatsu K; Hirabayashi Y; Sasaki T; Nakanishi K; Okada S; Kanaoka M; Nishinobu M; Masumoto S; Ohta Y
    Clin Ther; 1987; 9(6):602-6. PubMed ID: 2894244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of doxylamine succinate on thyroid hormone balance and enzyme induction in mice.
    Bookstaff RC; Murphy VA; Skare JA; Minnema D; Sanzgiri U; Parkinson A
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):584-94. PubMed ID: 8975784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE; Evans JS; Holmes D; Baker MT
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of phenobarbital and amidopyrine on the rate of decomposition of isoforms of cytochrome P-450 in mouse liver microsomes].
    Adrianov NV; Dovgiĭ AI; Khaĭlov PM
    Biokhimiia; 1989 Jul; 54(7):1120-5. PubMed ID: 2804167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.